Advanced search
Publication Cover
Pharmaceutical Development and Technology Volume 18, 2013 - Issue 1
Submit an article Journal homepage
491
Views
14
CrossRef citations to date
0
Altmetric
Research Article

Characterization, optimisation and process robustness of a co-processed mannitol for the development of orally disintegrating tablets

Josephine Lay Peng SohPharmaceutical Development, PharmaTherapeutics Pharmaceutical Sciences, Pfizer Worldwide R&D, Sandwich Laboratories, CT139NJ, UKCorrespondence[email protected]
,
Maud GrachetPharmaceutical Development, PharmaTherapeutics Pharmaceutical Sciences, Pfizer Worldwide R&D, Sandwich Laboratories, CT139NJ, UK
,
Mark WhitlockPharmaceutical Sciences & PGM Statistics, PharmaTherapeutics Pharmaceutical Sciences, Pfizer Worldwide R&D, Sandwich Laboratories, CT139NJ, UK
&
Timothy LukasPharmaceutical Development, PharmaTherapeutics Pharmaceutical Sciences, Pfizer Worldwide R&D, Sandwich Laboratories, CT139NJ, UK
Pages 172-185 | Received 25 Dec 2011, Accepted 02 Apr 2012, Published online: 14 May 2012

References

  • US FDA, 2008. Guidance for industry. Orally disintegrating tablets.
  • Park JH, Holman KM, Bish GA, Krieger DG, Ramlose DS, Herman CJ, Wu SH. An alternative to the USP disintegration test for orally disintegrating tablets. Pharm. Tech 2008;32:54–58.
  • Ichikawa K, Sakuma S, Yoshihara A, Miyazaki H, Funayama S, Ito K et al. Relationships between the amount of saliva and medications in elderly individuals. Gerodontology 2011;28:116–120.
  • Morita Y, Tsusima Y, Yasui M, Termoz R, Ajioka J, Takayama K. Evaluation of disintegration time of rapidly disintegrating tablets via a novel method utilizing a CCD camera. Chem. Pharm. Bull 2009;50:1181–1186.
  • Dor PJ, Fix JA. In vitro determination of disintegration time of quick-dissolve tablets using a new method. Pharm Dev Technol 2000;5:575–577.
  • Abdelbary G, Eouani C, Prinderre P, Joachim J, Reynier J, Piccerelle P. Determination of the in vitro disintegration profile of rapidly disintegrating tablets and correlation with oral disintegration. Int J Pharm 2005;292:29–41.
  • Pfister W, Gosh T. Orally disintegrating tablets: Products, technologies, and development issues. Pharm. Technol 2005;29:138–150.
  • Van Arnum P. Outsourcing Solid-Dosage Manufacturing. Pharm. Technol 2006;30:44–52.
  • Nachaegari SK, Bansal AK.. Coprocessed excipients for solid dosage forms. Pharm. Technol 2004;28:52–64.
  • Chan LW, Tang ESK, Heng PWS. Comparative study of the fluid dynamics of bottom spray fluid bed coaters. AAPS Pharm. Sci. Tech 2006;7: Article 37.
  • Wang LK, Heng PW, Liew CV. Classification of annular bed flow patterns and investigation on their influence on the bottom spray fluid bed coating process. Pharm Res 2010;27:756–766.
  • Soh JLP, Grachet M, Pang MOY, Coupe AJ, Goggin PL. Preliminary evaluation of a new co-processed excipient (Ludiflash®) for directly compressed orally disintegrating tablets. AAPS Annual Meeting and Poster Exposition. New Orleans, Louisiana, U.S.A. November 14–18 (2010).
  • Comoglu T. Formulation and evaluation of carbamazepine fast disintegrating tablets. Pharm Ind 2010;72:150–158.
  • Stoltenberg I, Breitkreutz J. Orally disintegrating mini-tablets (ODMTs)– a novel solid oral dosage form for paediatric use. Eur J Pharm Biopharm 2011;78:462–469.
  • Mullarney MP, Leyva N. Modeling pharmaceutical powder-flow performance using particle-size distribution data. Pharm. Tech 2009;33:126–134.
  • Pitt K, Newton JM, Stanley P. Tensile fracture of doubly-convex cylindrical discs under diameter loading. J. Mater. Sci 1998;23:2723–2728.
  • Jeong SH, Park K. Development of sustained release fast-disintegrating tablets using various polymer-coated ion-exchange resin complexes. Int J Pharm 2008;353:195–204.
  • Mullarney MP, Hancock BC. Improving the prediction of exceptionally poor tableting performance: an investigation into Hiestand’s “special case”. J Pharm Sci 2004;93:2017–2021.
  • Hancock BC, Colvin JT, MullarneyMP, Zinchu AV. The relative density of pharmaceutical powders, blends, dry granulations and immediate release tablets. Pharma. Technol 2003;64–80.
  • Sabir A, Evans B, Jain S. Formulation and process optimization to eliminate picking from market image tablets. Int J Pharm 2001;215:123–135.
  • Ndindayino F, Henrist D, Kiekens F, Vervaet C, Remon JP. Characterization and evaluation of isomalt performance in direct compression. Int. J. Pharm 1999;189:113–124.
  • Garr JSM, Rubenstein MH. Direct compression characteristics of xylitol. Int. J. Pharm 1990;64:223–226.
  • Morris LE, Moore JC, Schwartz JB. Characterization and performance of a new direct compression excipient for chewable tablets: Xylitab®. Drug Dev. Ind. Pharm 1996;22:925–932.
  • Johansson ME, Nicklasson M. Influence of mixing time, particle size, and colloidal silica on the surface coverage and lubrication of magnesium stearate. In: Reubinstein M. (Ed), Pharmaceutical Technology: Tableting Technology. Halstead Press, New York, pp. 43–50.(1987).
  • Late SG, Yu YY, Banga AK. Effects of disintegration-promoting agent, lubricants and moisture treatment on optimized fast disintegrating tablets. Int J Pharm 2009;365:4–11.
  • Derringer G, Suich R. Simultaneous Optimization of Several Response Variables. J. Qual. Technol 1980;12:214–219.
  • BASF. Ludiflash® – Excipient for fast disintegrating oral dosage forms. Direct compressible formula. Technical information (2007).

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.